{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Science", "lead_paragraph": "Many social scientists no longer think that America\u2019s shift to longer prison terms has been a help to poor neighborhoods.", "headline": {"seo": "Long Prison Terms Eyed as Contributing to Poverty", "main": "Prison and the Poverty Trap", "kicker": "Time and Punishment", "print_headline": "Prison and the Poverty Trap", "content_kicker": "Time and Punishment"}, "abstract": "Many social scientists feel that tougher prison sentences instituted in 1980s, once thought to help people in poor neighborhoods by reducing crime, have had opposite effect, disrupting lives and locking disadvantaged in cycle of poverty (Series: Time and Punishment).", "print_page": "1", "word_count": "2689", "_id": "5122abf4cf28d009de000992", "snippet": "Many social scientists no longer think that America\u2019s shift to longer prison terms has been a help to poor neighborhoods.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2013/02/19/science/long-prison-terms-eyed-as-contributing-to-poverty.html", "multimedia": [{"subtype": "wide", "url": "images/2013/02/19/science/19PRIS_SPAN/19PRIS-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2013/02/19/science/19PRIS_SPAN/19PRIS-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2013/02/19/science/19PRIS_SPAN/19PRIS-articleLarge.jpg", "height": 398, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2013/02/19/science/19PRIS_SPAN/19PRIS-articleLarge.jpg", "xlargeheight": "398"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2013/02/19/science/19PRIS_SPAN/19PRIS-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2013/02/19/science/19PRIS_SPAN/19PRIS-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Prisons and Prisoners", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Sociology", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Crime and Criminals", "is_major": "Y", "rank": "3", "name": "subject"}, {"value": "Poverty", "is_major": "Y", "rank": "4", "name": "subject"}, {"value": "Series", "is_major": "Y", "rank": "5", "name": "subject"}, {"value": "Sentences (Criminal)", "is_major": "Y", "rank": "6", "name": "subject"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "John", "lastname": "TIERNEY"}], "original": "By JOHN TIERNEY"}, "document_type": "article", "pub_date": "2013-02-19T00:00:00Z", "section_name": "Science"}, {"type_of_material": "News", "blog": [], "news_desk": "Magazine", "lead_paragraph": "Napoleon Chagnon tramped through a rain forest, uncovering the lives of indigenous tribes. But to some, he\u2019s anything but a hero.", "headline": {"main": "How Napoleon Chagnon Became Our Most Controversial Anthropologist", "print_headline": "Who Are the Real Savages?"}, "abstract": "Emily Eakin article profiles Napoleon Chagnon, well-known anthropologist who has been heavily criticized by many in his field for his research on elusive Yanomami Indians.", "print_page": "32", "word_count": "5292", "_id": "511b81a200315214fbb8ab28", "snippet": "Napoleon Chagnon tramped through a rain forest, uncovering the lives of indigenous tribes. But to some, he\u2019s anything but a hero.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2013/02/17/magazine/napoleon-chagnon-americas-most-controversial-anthropologist.html", "multimedia": [{"subtype": "wide", "url": "images/2013/02/17/magazine/17anthropologist1/17anthropologist1-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2013/02/17/magazine/17anthropologist1/17anthropologist1-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2013/02/17/magazine/17anthropologist1/17anthropologist1-articleLarge.jpg", "height": 600, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2013/02/17/magazine/17anthropologist1/17anthropologist1-articleLarge.jpg", "xlargeheight": "600"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2013/02/17/magazine/17anthropologist1/17anthropologist1-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2013/02/17/magazine/17anthropologist1/17anthropologist1-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Chagnon, Napoleon A", "is_major": "Y", "rank": "1", "name": "persons"}, {"value": "Anthropology", "is_major": "Y", "rank": "2", "name": "subject"}, {"value": "Amazon Jungle", "is_major": "N", "rank": "3", "name": "glocations"}, {"value": "Yanomami Indians", "is_major": "Y", "rank": "4", "name": "subject"}, {"value": "American Anthropological Assn", "is_major": "N", "rank": "5", "name": "organizations"}, {"value": "Neel, James V", "is_major": "N", "rank": "6", "name": "persons"}, {"value": "Lizot, Jacques", "is_major": "N", "rank": "7", "name": "persons"}, {"value": "Tierney, Patrick", "is_major": "N", "rank": "8", "name": "persons"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Emily", "lastname": "EAKIN"}], "original": "By EMILY EAKIN"}, "document_type": "article", "pub_date": "2013-02-17T00:00:00Z", "section_name": "Magazine"}, {"type_of_material": "News", "blog": [], "news_desk": "Sports", "lead_paragraph": "Lance Armstrong has experienced an extraordinary fall from grace in recent months, and the cancer-fighting foundation he founded has experienced some turbulence.", "headline": {"seo": "Livestrong Not Immune From Turmoil Surrounding Lance Armstrong", "main": "Livestrong Not Immune From Turmoil Surrounding Its Founder", "print_headline": "A Scandal\r\nLeaves Its Mark"}, "abstract": "Cancer-fighting foundation Livestrong faces uncertain future after founder Lance Armstrong's doping admission; much of organization's revenue comes from products heavily associated with Armstrong's image, and it remains unclear whether customers will continue to purchase licensed Livestrong merchandise following his disgrace.", "print_page": "1", "word_count": "923", "_id": "511ec5f6cf28d009de00011a", "snippet": "Lance Armstrong has experienced an extraordinary fall from grace in recent months, and the cancer-fighting foundation he founded has experienced some turbulence.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2013/02/16/sports/cycling/livestrong-not-immune-from-turmoil-surrounding-lance-armstrong.html", "multimedia": [{"subtype": "wide", "url": "images/2013/02/16/sports/TATTOOS1/TATTOOS1-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2013/02/16/sports/TATTOOS1/TATTOOS1-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2013/02/16/sports/TATTOOS1/TATTOOS1-articleLarge.jpg", "height": 817, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2013/02/16/sports/TATTOOS1/TATTOOS1-articleLarge.jpg", "xlargeheight": "817"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2013/02/16/sports/TATTOOS1/TATTOOS1-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2013/02/16/sports/TATTOOS1/TATTOOS1-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": "Cycling", "keywords": [{"value": "Livestrong Foundation", "is_major": "Y", "rank": "1", "name": "organizations"}, {"value": "Armstrong, Lance", "is_major": "Y", "rank": "2", "name": "persons"}, {"value": "Doping (Sports)", "is_major": "Y", "rank": "3", "name": "subject"}, {"value": "Philanthropy", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "Bicycles and Bicycling", "is_major": "Y", "rank": "5", "name": "subject"}, {"value": "Cancer", "is_major": "N", "rank": "6", "name": "subject"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Mary", "lastname": "PILON"}, {"firstname": "Andrew", "middlename": "W.", "lastname": "LEHREN", "rank": 2, "role": "reported", "organization": ""}], "original": "By MARY PILON and ANDREW W. LEHREN"}, "document_type": "article", "pub_date": "2013-02-16T00:00:00Z", "section_name": "Sports"}, {"type_of_material": "News", "blog": [], "news_desk": "Metro", "lead_paragraph": "The case of Ryan Eisner leaves questions about why the drug that saved him failed with other patients.", "headline": {"seo": "For Ryan Eisner, College Athlete, Narrow Escape From Sepsis Leaves a Mystery", "main": "Athlete\u2019s Near-Death From Sepsis, and His Mysterious Recovery", "kicker": "About New York", "print_headline": "Athlete\u2019s Near-Death From Sepsis, and His Mysterious Recovery", "content_kicker": "About New York"}, "abstract": "Jim Dwyer About New York column examines case of star college athlete Ryan Eisner of Queens, who survived sepsis after his doctors used a risky, controversial drug from Eli Lilly & Co to treat him in an advanced stage of sepsis; Eisner was not expected to recover, and the drug has since been pulled from the market because of its failure rate; Eisner's recovery remains a mystery.", "print_page": "21", "word_count": "789", "_id": "511d966600315214fbb8baf4", "snippet": "The case of Ryan Eisner leaves questions about why the drug that saved him failed with other patients.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2013/02/15/nyregion/for-ryan-eisner-college-athlete-narrow-escape-from-sepsis-leaves-a-mystery.html", "multimedia": [{"width": 190, "url": "images/2013/02/15/nyregion/ABOUT/ABOUT-thumbWide.jpg", "height": 126, "subtype": "wide", "legacy": {"wide": "images/2013/02/15/nyregion/ABOUT/ABOUT-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"width": 600, "url": "images/2013/02/15/nyregion/ABOUT/ABOUT-articleLarge.jpg", "height": 400, "subtype": "xlarge", "legacy": {"xlargewidth": "600", "xlarge": "images/2013/02/15/nyregion/ABOUT/ABOUT-articleLarge.jpg", "xlargeheight": "400"}, "type": "image"}, {"width": 75, "url": "images/2013/02/15/nyregion/ABOUT/ABOUT-thumbStandard.jpg", "height": 75, "subtype": "thumbnail", "legacy": {"thumbnailheight": "75", "thumbnail": "images/2013/02/15/nyregion/ABOUT/ABOUT-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"rank": "1", "is_major": "Y", "value": "Sepsis", "name": "subject"}, {"rank": "2", "is_major": "N", "value": "Septic Shock", "name": "subject"}, {"rank": "3", "is_major": "Y", "value": "Eisner, Ryan", "name": "persons"}, {"rank": "5", "is_major": "N", "value": "Immune System", "name": "subject"}, {"rank": "6", "is_major": "Y", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "7", "is_major": "Y", "value": "Infections", "name": "subject"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "firstname": "Jim", "rank": 1, "lastname": "DWYER"}], "original": "By JIM DWYER"}, "document_type": "article", "pub_date": "2013-02-15T00:00:00Z", "section_name": "N.Y. / Region"}, {"type_of_material": "News", "blog": [], "news_desk": "Business", "lead_paragraph": "Extending Medicaid\u2019s drug discounts to low-income seniors on Medicare is likely to face staunch opposition.", "headline": {"seo": "Uphill Road for Plan to Cut Government&#8217;s Drug Costs", "main": "Uphill Road for Plan to Cut Government\u2019s Drug Costs", "print_headline": "Uphill Road for Plan to Cut Government\u2019s Drug Costs"}, "abstract": "Pres Obama's proposal requiring drug companies to extend Medicaid\u2019s drug discounts to low-income seniors on Medicare is likely to face staunch opposition from Republicans, some Democrats and powerful pharmaceutical industry, making passage unlikely.", "print_page": "2", "word_count": "724", "_id": "511d890500315214fbb8bacf", "snippet": "Extending Medicaid\u2019s drug discounts to low-income seniors on Medicare is likely to face staunch opposition.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2013/02/15/business/uphill-road-for-plan-to-cut-governments-drug-costs.html", "multimedia": [{"subtype": "wide", "url": "images/2013/02/15/business/Price/Price-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2013/02/15/business/Price/Price-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2013/02/15/business/Price/Price-articleLarge.jpg", "height": 400, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2013/02/15/business/Price/Price-articleLarge.jpg", "xlargeheight": "400"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2013/02/15/business/Price/Price-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2013/02/15/business/Price/Price-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Medicare", "is_major": "Y", "rank": "1", "name": "subject"}, {"value": "Medicaid", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "3", "name": "subject"}, {"value": "State of the Union Message (US)", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "Health Insurance and Managed Care", "is_major": "N", "rank": "5", "name": "subject"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Katie", "lastname": "THOMAS"}, {"organization": "", "role": "reported", "rank": 2, "firstname": "Robert", "lastname": "PEAR"}], "original": "By KATIE THOMAS and ROBERT PEAR"}, "document_type": "article", "pub_date": "2013-02-15T00:00:00Z", "section_name": "Business Day"}], "meta": {"hits": 5, "offset": 0, "time": 24}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}